Medical Education

Medical Education Grants

Jazz Pharmaceuticals (JAZZ) is committed to improving patient outcomes and providing support in compliance with local regulations.

Therapeutic Areas of Interest



  • Educate on the screening, diagnosis and treatment of narcolepsy in pediatric patients
  • Educate on the screening, diagnosis and management of narcolepsy in adults including recognition of cataplexy
  • Educate Payers on diagnostic testing, debilitating nature, costs and potential impact of appropriate treatment of
  • Educate on the MOA of narcolepsy treatments
  • Educate on screening, diagnosis, and management of idiopathic hypersomnia and other hypersomnolence
  • Educate on narcolepsy comorbidities (e.g., depression, anxiety, sleep apnea, restless legs syndrome, cardiovascular health)

Excessive Daytime Sleepiness in Obstructive Sleep Apnea (EDS in OSA)

  • Educate on EDS in OSA to include:

    • Pathophysiology
    • Prevalence
    • Persistence
    • Diagnosis
    • Associated Burden
  • Educate on new therapies to treat ES in OSA, including MOA, efficacy and safety data


Acute Myeloid Leukemia (AML)

  • Educate on novel treatment options (and their MOA) in secondary AML patients
  • Educate on identification and timely, actionable diagnosis of high risk AML subsets – AML-MRC, t-AML
  • Educate on the feasibility and potential management of secondary AML patients in the outpatient setting
  • Educate on the AML treatment paradigm including induction and consolidation chemotherapy selection in
    relation to transplant
  • Educate on clinical and economic burden of secondary AML and value of new treatments
  • Educate on fitness assessment and eligibility for intensive chemotherapy in secondary AML patients

Veno Occlusive Disease (VOD)

  • Educate on the recognition, diagnosis and early intervention of VOD/SOS
  • Educate on VOD diagnostic criteria and severity grading in both adult and pediatric patients
  • Educate on the clinical and economic burden of VOD/SOS and other post-transplant complications associated
    with endothelial cell damage
  • Educate on the pathophysiology and progressive nature of VOD and other post-transplant complications
    associated with endothelial cell damage (i.e., GvHD, TA-TMA, IRI, CRES)
  • Educate on the efficacy, safety and patient management of current and new therapies in the treatment and
    prevention of VOD/SOS and other post-transplant complications associated with endothelial cell damage

Small Cell Lung Cancer (US Only)

View our current requests for application.

Eligible educational grant applicants include the following (not an exhaustive list):

  • Medical Schools
  • Medical Associations/Medical Societies
  • Hospitals/Medical Centers
  • Medical Education Providers

This system is currently accepting requests for medical education meetings, conferences, or symposia; medical center grand rounds lectures; fellowships; enduring medical education activities; and similar educational activities.

In Europe and Rest of World (EU/RoW) the system is also accepting requests for goods (such as books, printing, materials, equipment) and services (such as administrative support, personnel and tools).

The following grant requests are not covered by the educational grant request process: requests for funding educational activities that are promotional in nature (e.g., brand-specific promotional speaker activities); requests for funding activities related to promotion of a commercial product (e.g., commercial exhibits); and operational funding for patient advocacy organizations.

How to Apply

Grant requests to support US Medical Education and Medical and Education Goods and Services (MEGS) for Europe and Rest of World (EU/RoW) should be submitted using the Jazz Pharmaceuticals Request Management System.

The Jazz Pharmaceuticals (JAZZ) Grant Management System requires that all grant requests should be received by JAZZ in complete form at least 60 days prior to the commencement of the educational activity for consideration.

The system will guide applicants through the process of determining the request type and the required documents for each request.

Jazz Pharmaceuticals does not control or influence the content of programs or the selection of speakers, authors, or faculty planners.

All decisions regarding support are at the discretion of JAZZ and will be communicated by email.

Submission of a request does not guarantee support.

For more information, or for questions regarding the status of a grant request, please email for requests from the US.

For medical education requests from the EU/RoW, please contact